|
US8933236B2
(en)
|
2012-05-22 |
2015-01-13 |
Xenon Pharmaceuticals Inc. |
N-substituted benzamides and methods of use thereof
|
|
SE0102299D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
|
RU2005113713A
(ru)
|
2002-10-03 |
2006-01-20 |
Новартис АГ (CH) |
Замещенные (тиазол-2-ил)амиды или сульфонамиды в качестве активаторов глюкокиназы, которые могут применяться при лечении диабета типа 2
|
|
GB0226930D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0226931D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
JP4621198B2
(ja)
*
|
2003-02-11 |
2011-01-26 |
プロシディオン・リミテッド |
トリ（シクロ）置換アミドグルコキナーゼ活性化化合物
|
|
CA2560689C
(en)
|
2004-04-02 |
2011-03-01 |
Novartis Ag |
Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes
|
|
JP2007530631A
(ja)
|
2004-04-02 |
2007-11-01 |
ノバルティス アクチエンゲゼルシャフト |
チアゾロピリジン誘導体、それを含む医薬組成物およびグルコキナーゼ介在性状態の処置法
|
|
WO2006058923A1
(en)
|
2004-12-03 |
2006-06-08 |
Novo Nordisk A/S |
Heteroaromatic glucokinase activators
|
|
KR20110084339A
(ko)
|
2005-07-09 |
2011-07-21 |
아스트라제네카 아베 |
당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한 헤테로아릴 벤즈아미드 유도체
|
|
JPWO2007026761A1
(ja)
*
|
2005-08-31 |
2009-03-12 |
アステラス製薬株式会社 |
チアゾール誘導体
|
|
JP2007063225A
(ja)
*
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
JP2009509988A
(ja)
|
2005-09-29 |
2009-03-12 |
サノフィ−アベンティス |
フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用
|
|
GT200600429A
(es)
*
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
|
GT200600428A
(es)
*
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
|
US20070197532A1
(en)
*
|
2005-11-18 |
2007-08-23 |
Cao Sheldon X |
Glucokinase activators
|
|
US8034822B2
(en)
|
2006-03-08 |
2011-10-11 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
US8211925B2
(en)
*
|
2006-04-28 |
2012-07-03 |
Transtech Pharma, Inc. |
Benzamide glucokinase activators
|
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
|
JP5386350B2
(ja)
*
|
2006-05-31 |
2014-01-15 |
タケダ カリフォルニア インコーポレイテッド |
グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体
|
|
FR2903985B1
(fr)
|
2006-07-24 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
|
EP2261216A3
(en)
|
2006-07-24 |
2011-12-14 |
F. Hoffmann-La Roche AG |
Pyrazoles as glucokinase activators
|
|
FR2904316B1
(fr)
|
2006-07-31 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
|
|
US20080107725A1
(en)
*
|
2006-10-13 |
2008-05-08 |
Albano Antonio A |
Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
|
|
US7902248B2
(en)
*
|
2006-12-14 |
2011-03-08 |
Hoffmann-La Roche Inc. |
Oxime glucokinase activators
|
|
US8163779B2
(en)
|
2006-12-20 |
2012-04-24 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
WO2008074694A1
(en)
*
|
2006-12-20 |
2008-06-26 |
F. Hoffmann-La Roche Ag |
Crystallization of glucokinase activators
|
|
TW200831081A
(en)
*
|
2006-12-25 |
2008-08-01 |
Kyorin Seiyaku Kk |
Glucokinase activator
|
|
FR2910473B1
(fr)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
|
|
EP2105435A4
(en)
*
|
2007-01-10 |
2011-06-15 |
Mitsubishi Tanabe Pharma Corp |
Hydrazone derivative
|
|
PT2129654E
(pt)
|
2007-02-09 |
2014-09-04 |
Metabasis Therapeutics Inc |
Antagonistas do receptor de glucagina
|
|
EP2116533B1
(en)
*
|
2007-03-07 |
2013-07-10 |
Kyorin Pharmaceutical Co., Ltd. |
Glucokinase activator
|
|
WO2008116107A2
(en)
*
|
2007-03-21 |
2008-09-25 |
Takeda San Diego, Inc. |
Piperazine derivatives as glucokinase activators
|
|
CA2682304A1
(en)
|
2007-04-04 |
2008-10-16 |
F. Hoffmann-La Roche Ag |
Microbial reduction of an acetoxyketone
|
|
EP2148878A4
(en)
*
|
2007-04-20 |
2011-08-10 |
Merck Canada Inc |
NEW HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME-A-DELTA-9-DESATURASE
|
|
WO2009022179A2
(en)
*
|
2007-08-14 |
2009-02-19 |
Astrazeneca Ab |
Glucokinase activators in the treatment of osteoarthritis
|
|
WO2009047798A2
(en)
*
|
2007-10-08 |
2009-04-16 |
Advinus Therapeutics Private Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
|
US8329707B2
(en)
|
2008-01-18 |
2012-12-11 |
Astellas Pharma Inc. |
Substituted pyrazine compounds
|
|
US8258134B2
(en)
|
2008-04-16 |
2012-09-04 |
Hoffmann-La Roche Inc. |
Pyridazinone glucokinase activators
|
|
US7741327B2
(en)
*
|
2008-04-16 |
2010-06-22 |
Hoffmann-La Roche Inc. |
Pyrrolidinone glucokinase activators
|
|
HUE025224T2
(en)
|
2008-04-28 |
2016-02-29 |
Kyorin Seiyaku Kk |
Ciklopentilakrilsav amide derivatives
|
|
CN104803891B
(zh)
|
2008-08-13 |
2017-10-20 |
症变治疗公司 |
胰高血糖素拮抗剂
|
|
UA104742C2
(uk)
*
|
2008-12-19 |
2014-03-11 |
Эли Лилли Энд Компани |
Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази
|
|
US20110021570A1
(en)
*
|
2009-07-23 |
2011-01-27 |
Nancy-Ellen Haynes |
Pyridone glucokinase activators
|
|
US20110040091A1
(en)
|
2009-08-13 |
2011-02-17 |
Stephan Bachmann |
Process for the preparation of (r)-2-phenyl propionic acid derivatives
|
|
US20110054174A1
(en)
|
2009-08-28 |
2011-03-03 |
Stephan Bachmann |
Process for the preparation of a glucokinase activator compound
|
|
US8962627B2
(en)
|
2009-10-30 |
2015-02-24 |
Prestwick Chemical, Inc. |
Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
|
|
US8222416B2
(en)
|
2009-12-14 |
2012-07-17 |
Hoffmann-La Roche Inc. |
Azaindole glucokinase activators
|
|
EP3199623B1
(en)
|
2010-03-31 |
2021-07-28 |
The Scripps Research Institute |
Reprogramming cells
|
|
WO2011130459A1
(en)
|
2010-04-14 |
2011-10-20 |
Bristol-Myers Squibb Company |
Novel glucokinase activators and methods of using same
|
|
US8178689B2
(en)
|
2010-06-17 |
2012-05-15 |
Hoffman-La Roche Inc. |
Tricyclic compounds
|
|
AR082590A1
(es)
|
2010-08-12 |
2012-12-19 |
Hoffmann La Roche |
Inhibidores de la tirosina-quinasa de bruton
|
|
EP3067346A1
(en)
*
|
2010-11-16 |
2016-09-14 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
|
|
US8470866B2
(en)
|
2011-05-03 |
2013-06-25 |
Hoffmann-La Roche Inc. |
Isoindolinone derivatives
|
|
JP6014154B2
(ja)
|
2011-10-31 |
2016-10-25 |
ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用
|
|
WO2013064984A1
(en)
|
2011-10-31 |
2013-05-10 |
Xenon Pharmaceuticals Inc. |
Biaryl ether sulfonamides and their use as therapeutic agents
|
|
BR112015000187A2
(pt)
*
|
2012-07-06 |
2017-06-27 |
Genentech Inc |
benzamidas substituídas com n e métodos de uso das mesmas
|
|
KR20150131233A
(ko)
|
2013-03-14 |
2015-11-24 |
제넨테크, 인크. |
치환된 트리아졸로피리딘 및 이의 사용 방법
|
|
US9493429B2
(en)
|
2013-03-15 |
2016-11-15 |
Genentech, Inc. |
Substituted benzoxazoles and methods of use thereof
|
|
SG11201601291QA
(en)
|
2013-08-23 |
2016-03-30 |
Parion Sciences Inc |
Dithiol mucolytic agents
|
|
ES2929576T3
(es)
|
2013-10-08 |
2022-11-30 |
Acetylon Pharmaceuticals Inc |
Combinaciones de inhibidores de histona deacetilasa 6 y el inhibidor de Her2 lapatinib para el uso en el tratamiento del cáncer de mama
|
|
ES2862126T3
(es)
|
2013-10-10 |
2021-10-07 |
Acetylon Pharmaceuticals Inc |
Compuestos de pirimidín-hidroxiamida como inhibidores de histona desacetilasa
|
|
EP3060217B1
(en)
|
2013-10-24 |
2022-06-08 |
Mayo Foundation for Medical Education and Research |
Treatment of polycystic diseases with an hdac6 inhibitor
|
|
CR20160296A
(es)
|
2013-11-27 |
2016-09-20 |
Genentech Inc |
Benzamidas sustituidas y métodos para usarlas
|
|
EP2878339A1
(en)
|
2013-12-02 |
2015-06-03 |
Siena Biotech S.p.A. |
SIP3 antagonists
|
|
MX2016007251A
(es)
|
2013-12-03 |
2016-09-07 |
Acetylon Pharmaceuticals Inc |
Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores.
|
|
US9464073B2
(en)
|
2014-02-26 |
2016-10-11 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
|
|
EP3154956A4
(en)
|
2014-06-12 |
2018-01-17 |
Ligand Pharmaceuticals, Inc. |
Glucagon antagonists
|
|
EA201790142A1
(ru)
|
2014-07-07 |
2017-07-31 |
Эситайлон Фармасьютикалз, Инк. |
Лечение лейкоза ингибиторами гистондеацетилазы
|
|
WO2016007534A1
(en)
|
2014-07-07 |
2016-01-14 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
MA40530A
(fr)
|
2014-08-27 |
2017-07-05 |
Prexton Therapeutics Sa |
Nouveau dérivé d'oxime de chromone et son utilisation comme modulateur allostérique de récepteurs métabotropiques du glutamate
|
|
AU2015356779A1
(en)
|
2014-12-05 |
2017-07-13 |
University of Modena and Reggio Emilia |
Combinations of histone deacetylase inhibitors and bendamustine for use in the treatment of lymphoma
|
|
SG11201705790SA
(en)
|
2015-01-30 |
2017-08-30 |
Parion Sciences Inc |
Novel monothiol mucolytic agents
|
|
JP2018520986A
(ja)
|
2015-04-30 |
2018-08-02 |
パリオン・サイエンシィズ・インコーポレーテッド |
ジチオール粘液溶解剤の新規なプロドラッグ
|
|
EP3297989A1
(en)
|
2015-05-22 |
2018-03-28 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
US10272084B2
(en)
|
2015-06-01 |
2019-04-30 |
Regenacy Pharmaceuticals, Llc |
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
|
|
SI3341380T1
(sl)
|
2015-08-27 |
2020-02-28 |
Prexton Therapeutics Sa |
Možgansko-penetranten derivat kromon oksima za terapijo levodopa-inducirane diskinezije
|
|
CN108137477A
(zh)
|
2015-08-27 |
2018-06-08 |
基因泰克公司 |
治疗化合物及其使用方法
|
|
CN108290881B
(zh)
|
2015-09-28 |
2021-12-07 |
健泰科生物技术公司 |
治疗性化合物和其使用方法
|
|
EP3380466A1
(en)
|
2015-11-25 |
2018-10-03 |
Genentech, Inc. |
Substituted benzamides useful as sodium channel blockers
|
|
US10766858B2
(en)
|
2016-03-30 |
2020-09-08 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
EP3445364A4
(en)
|
2016-04-19 |
2019-11-27 |
Acetylon Pharmaceuticals, Inc. |
HDAC INHIBITORS, ONLY OR IN COMBINATION WITH BTK INHIBITORS, FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
|
|
CN109715637B
(zh)
|
2016-07-22 |
2022-04-05 |
百时美施贵宝公司 |
葡萄糖激酶激活剂及其使用方法
|
|
MX388175B
(es)
|
2016-10-17 |
2025-03-19 |
Genentech Inc |
Compuestos terapéuticos y métodos para utilizarlos
|
|
EP3601273B1
(en)
|
2017-03-24 |
2021-12-01 |
Genentech, Inc. |
4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors
|
|
EP3752249A1
(en)
|
2018-02-13 |
2020-12-23 |
Ligand Pharmaceuticals, Inc. |
Glucagon receptor antagonists
|
|
CN112041313A
(zh)
|
2018-02-26 |
2020-12-04 |
基因泰克公司 |
吡啶-磺酰胺化合物及其针对疼痛和相关疾患的用途
|
|
JP2021519788A
(ja)
|
2018-03-30 |
2021-08-12 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ナトリウムチャネル阻害剤としての縮合環ヒドロピリド化合物
|
|
TW202003490A
(zh)
|
2018-05-22 |
2020-01-16 |
瑞士商赫孚孟拉羅股份公司 |
治療性化合物及其使用方法
|